IP Library Granted Patent US 7,038,019
Granted Patent B2
US 7,038,019 · App. 10/012,149 · Granted May 2, 2006

Antibodies to PRO1410

Assignee: Genentech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,038,019
App. No.
10/012,149
Granted
May 2, 2006
Kind
B2
Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims (4)

1. An antibody, or fragment thereof, that specifically binds to the polypeptide of (SEQ ID NO: 271).

2. The antibody of claim 1 which is a monoclonal antibody.

3. The antibody of claim 1 which is a humanized antibody.

4. The antibody of claim 1 which is labeled.

Continuity (6)
Continuation 0994637400 · Sep 4, 2001
Continuation PCTUS000434200 · Feb 18, 2000
Continuation In Part 0940329700
Provisional Application 6016250600 · Oct 29, 1999
Provisional Application 6010147600 · Sep 23, 1998
Related Publication 20050043520A1 · Feb 24, 2005